<DOC>
	<DOC>NCT00805454</DOC>
	<brief_summary>Determine the degree of striatal D2 receptor occupancy induced by OPC-34712 at differenht dose levels in healthy volunteers.</brief_summary>
	<brief_title>Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712</brief_title>
	<detailed_description>Subjects will receive a dose of study medication and will undergo a PET scan at 4 hrs and 23.5 hours post dose. Subjects will remain in the clinic from Day-1 to Day 7 for PK sample collection and safety monitoring. Subjects will return to the clinic on Day 10 for a follow-up safety assessment.</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Males and nonchild bearing potential females between 18 and 45 years of age, inclusive. BMI between 19 and 32 kg/m2, inclusive. Condition or history which may present a safety concern to the subject or interfere with outcome variables. History of or current drug or alcohol abuse, hepatitis, AIDS, or drug allergy. Use of prescription, overthecounter, or herbal medication, or vitamin supplements within 14 days or antibiotics within 30 days. Use of tobacco products or daily exposue to second hand smoke. Blood pressure higher than 140/90 mmHg or lower than 100/50 mmHg: heart rate outside 40 to 90 beats/minute. History of serious mental disorder.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Phase I</keyword>
	<keyword>Pet Scan</keyword>
</DOC>